Immunohistochemical Analysis and Prognostic Value of Cathepsin D Determination in Laryngeal Squamous Cell Carcinoma

Journal of Chemical Information and Computer Sciences

Volumn 40, Issue 3, 2000, Pages 545-549

  Seiwerth, Sven ^a   Štambuk, Nikola ^b   Konjevoda, Paško ^a   Mašić, Nikola ^b   Vasilj, Ankica ^a   Bura, Miljenko ^a   Klapan, Ivo ^a   Manojlović, Spomenka ^a   Crossed D signanić, Davor ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c ENT Department County Hospital   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D;

ARTICLE; ENZYMOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; SURVIVAL;

CARCINOMA, SQUAMOUS CELL; CATHEPSIN D; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0034186079     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci990075q     Document Type: Article

References (31)

1. Capony, F.; Morrisset, M.; Barrett, A. J.; Capony, J. P.; Broquet, P.; Vignon, F.; Chambon, M.; Louist, P.; Rochefort, H. Phosphorylation, glycosilation and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J. Cell Biol. 1987, 104, 253-262.
2. Montcurrier, P.; Mangeant, PH.; Salazar, G.; Morisset, M.; Sahuquet, A.; Rochefort, H. Cathepsin D in breast cancer can digest extracellular matrix in large acid vesicles. Cancer Res. 1990, 50, 6045-6054.
3. Kute, T. E.; Shao, Z. M.; Sugg, K.; Long, R. T.; Russell, G. B.; Case, D. Cathepsin D as prognostic indicator for node-negative breast cancer patients using both immunoassay and enzymatic assay. Cancer Res. 1992, 52, 5198-5203.
4. Rochefort H.; Capony, F.; Garcia, M. Cathepsin D: A protease involved in breast cancer metastasis. Cancer Metastasis Rev. 1990, 9, 321-331.
5. Leto, G.; Gebbia, N.; Rausa, L.; Tuminello, FM. Cathepsin D in the malignant progression of neoplastic diseases. Anticancer Res. 1992, 12, 235-240.
6. Marsigliante, S.; Resta, L.; Leo, G.; Mazzotta, D.; d'Amore, R.; Biscozzo, L.; Storelli, C. Expression of cathepsin D in malignant an in the corresponding nonmalignant node-negative laryngeal samples: correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone. Cancer Lett. 1993, 68, 135-142.
7. Maurizi, M.; Almadori G.; Cadoni, G.; Scambia, G.; Ottaviani, F.; Ferrandina, G.; Paludetti, G.; D'Abramo, G.; Manusco, S. Cathepsin D concentration in primary laryngeal cancer: correlation with clinicopathnlogical parameters, EGFR status and prognosis. Int. J. Cancer 1996, 69, 105-109.
8. Ferrandina, G.; Scambia, G.; Benedetti, P.; Almadori, G.; Paludetti, G.; Cadoni, G.; Distefano, M.; Maurizi, M.; Mancuso, S. Cathepsin D in primary squamous laryngeal tumors: correlation with clinicopathological parameters and receptor status. Cancer Lett. 1992, 67, 133-138.
9. American Joint Commitee on Cancer. Manual for Staging on Cancer; JB Lippincot: Philadelphia, PA, 1988; p 43.
10. Konjevoda, P.; Nasić, M.; Ćurković, T.; Sikirić, P.; Seiwerth, S.; Štambuk, N. Effects of BPC 157 on the healing of corneal lesions. In Uveitis Today: Ohno, S., Aoki, K., Usui, M., Uchio, E., Eds.; Elsevier: Amsterdam, 1998; pp 311-314.
11. Bartels, P. H.; Thompson, D.; Weber, J. E. In Image Analysis - A primer for Pathologist; Marchevsky, A. M., Bartels P. H., Eds.; Raven Press: New York, 1994; Chapter 7, p 207.
12. Afifi, A. A.; Clark, V. Computer-aided Multivariate Analysis; Chapman & Hall: London, 1996; Chapter 13, p 306.
13. Quinlan, J. R. Induction of Decision Trees. Machine Learning 1986, 1, 81-106.
14. Blazadonakis, M.; Moustakis, V.; Charissis, G. Deep assessment of machine learning techniques using patient treatment in acute abdominal pain in children. Artif. Intell. Med. 1996, 8, 527-542.
15. Quinlan, J. R. C4.5: Programs for Machine Learning; Morgan Kaufmann: San Mateo, 1993; pp 3-41.
16. Quinlan, J. R. Rule induction with statistical data - a comparison with multiple regression. J. Operat. Res. Soc. 1987, 38, 347-352.
17. Štambuk, N.; Mašić, N.; Brinar, V.; Trbojević-Čepe, M.; Štambuk, V.; Rabatić, S.; Marotti, T.; Šverko, V.; Marušić-Della Marina, B.; Brzović, Z.; Zurak, N.; Svoboda-Beusan, I.; Mažuran, R.; Martinić, R.; Štambuk, A.; Karaman, K.; Gagro, A.; Rudolf, M.; Malenica, B.; Pokrić, B. Machine learning approach defines immune response during met-enkephalin immunotherapy in multiple sclerosis and optic neuritis. In Advances in Systems, Signals, Control and Computers, vol. II; Bajić, V. B., Ed.; International Association for the Advancement of Methods for System Analysis and Design (IAAMSAD) and Academy of Nonlinear Sciences (ANS): South Africa, 1998; pp 302-305.
18. Mitchelt, T. M. Machine Learning; McGraw-Hill: Singapore, 1997; pp 55-80.
19. Campbell, M. J.; Machin, D. Medical Statistics; J. Wiley & Sons: Chicester, 1995; Chapter 3, pp 34-35, 74.
20. Tandon, A. K.; Clark, G. M.; Chamness, G. C.; Chirgwin, J. M.; McGuire, W. L. Cathepsin D and prognosis in breast cancer. N. Engl. J. Med. 1990, 322, 297-302.
21. Schultz, D. C.; Bazel, S.; Wright, L. M.; Tucker, S.; Lange, M. K.; Tachovsky, T.; Lomgo, S.; Niedbala, S.; Alhadeff, J. A. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls. Cancer Res. 1994, 54, 48-54.
22. Goldmann, F. J.; Biess, B.; Lippold, A.; Suter, L.; Westhoff, U. Prognostic classification of malignant melanomas by combining clinical, histological, and immunohistochemical parameters. Oncology 1999, 56, 208-214.
23. Tuminello, F. M.; Gebbia, N.; Pizzolanti, G.; Russo, A.; Bazan, V.; Leto, G. Cathepsin D content in colorectal cancer. Oncology 1995, 52, 237-242.
24. Zeillinger, R.; Swoboda, H.; Machacek, E.; Nekahm, D.; Sliutz, G.; Knogler, W.; Speiser, P.; Swoboda, E.; Kubista, E. Expression of cathepsin D in head and neck cancer. Eur. J. Cancer 1992, 28A, 1413- 1415.
25. Parham, D.; Whitaker, J. N.; Costan, W.; Berard, W. Cellular distribution of cathepsin D in childhood tumors. Arch. Pathol. Lab. Med. 1985, 109, 250-255.
26. Robson, D. K.; Ironside, J. W.; Reid, W. A.; Bogue, P. R. Immunolocalization of cathepsin D in the human central nervous system and central nervous system neoplasms. Neuropathol. Appl. Neurobiol. 1990, 16, 39-44.
27. Resta, L.; Fiorella, R.; di Nicola, V.; Marzullo, A.; Boticella, M. A.; Maiorano, E. Cathepsin D in laryngeal carcinoma. Preliminary report. Bolletino-Societa Italiana Biologia Sperimentale 1995, 71, 257-261.
28. Marsigliante, S.; Biscozzo, L.; Resta, L.; Leo, G.; Mottaghi, A.; Maiorano, E.; Collucci, G.; Storelli, C. Immunohistochemical and immunoradiometric evaluations of total cathepsin-D in human larynx. Eur. J. Cancer 1994, 30B, 51-55.
29. Marsigliante, S.; Mottaghi, A.; Muscella, A.; Cirado, V.; Leo, G.; Storelli, C. Effect of tumor size on the association between PS2 and cathepsin D in primary breast cancer. Int. J. Oncol. 1995, 6, 69-73.
30. Theodoropoulos, G. E.; Panoussopoulos, D.; Lazaris, A. C.; Golematis, B. C. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma. J. Surg. Oncol. 1997, 65, 242-248.
31. Allgayer, H.; Babic, R.; Grutzner, K. U.; Beyer, B. C. M.; Tarabichi, A.; Schildberg. F. W.; Heiss, M. M. Tumor-associated proteases and inhibitors in gastric cancer - analysis of prognostic impact and individual risk protease patterns. Clin. Exp. Metastasis 1998, 16, 62-73.